Form S-3/A GYRE THERAPEUTICS, INC.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall St futures gain as chip stocks extend recovery; earnings in focus
- Oil prices rise nearly 2% on fresh attacks by US and Iran
- Chip stocks extend global rebound following last week's rout
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- Danaher shares tumble despite earnings beat
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
Gyre Therapeutics (GYRE) files for 31.03M share offering by selling stockholders
July 13, 2026 5:13 PM EDTGyre Therapeutics (NASDAQ: GYRE) has filed for up to 31,302,863 share offering by selling stockholders.
... More